New Study Highlights Results of Diversey's Oxivir Tb Against MDROs
A recent study by William Rutala, PhD, MPH, published in the November 2012 issue of Infection Control and Hospital Epidemiology, showed that healthcare disinfectants containing improved hydrogen peroxide had greater efficacy than standard hydrogen peroxide or quaternary ammonium chloride (quat) disinfectants against community acquired methicillin-resistant Staphylococcus aureus (CA-MRSA), vancomycin-resistant Enterococcus (VRE) and multidrug-resistant (MDR) Acinetobacter baumannii. Diverseys Oxivir® Tb, based on patented AHP technology , is one of the improved hydrogen peroxide products referenced in the study. The Oxivir Tb product is further differentiated in the market by having the best safety profile possible for a disinfectant.Â
Numerous published studies have shown that environmental contamination plays a role in the transmission of healthcare-associated pathogens including MRSA, VRE, and MDR A. baumannii, says Carolyn Cooke, vice president of the healthcare sector at Diversey, now part of Sealed Air. This research demonstrates that Oxivir Tb, which has an excellent safety and environmental profile, offered exceptional efficacy at 30 seconds and 1-minute contact times against key pathogens commonly found in the healthcare environment.
AHP-based products, such as Oxivir Tb, are the only improved hydrogen peroxide disinfectants currently on the market that provide this combination of efficacy and safety. In all six EPA toxicity studies, Oxivir Tb falls into the category with lowest level of hazard, creating a safer environment for staff and patients.
Diverseys Oxivir line of products were introduced in 2006 to provide an alternative to traditional disinfectants by delivering fast acting, broad spectrum disinfection, with enhanced cleaning power that is friendly to staff, patients and surfaces. The active ingredient breaks down into oxygen and water within minutes after application.
Diversey is a business of Sealed Air Corp., a leader in food safety and security, facility hygiene and product protection.
Vet IP Roundtable 2: Infection Control and Biosecurity Challenges in Veterinary Care
March 31st 2025Veterinary IPs highlight critical gaps in cleaning protocols, training, and biosecurity, stressing the urgent need for standardized, animal-specific infection prevention practices across diverse care settings.
Invisible, Indispensable: The Vital Role of AHRQ in Infection Prevention
March 25th 2025With health care systems under strain and infection preventionists being laid off nationwide, a little-known federal agency stands as a last line of defense against preventable patient harm. Yet the Agency for Healthcare Research and Quality (AHRQ) is now facing devastating cuts—threatening decades of progress in patient safety.
From Shortages to Security: How Reusable Health Care Textiles Can Transform Infection Prevention
March 7th 2025Reusable health care textiles enhance infection prevention, reduce waste, and strengthen supply chains. Hygienically clean textiles offer a sustainable, cost-effective alternative to disposable PPE, ensuring patient safety and environmental responsibility.
